After months of laboratory work and successful testing in rhesus macaque monkeys, researchers at Johnson & Johnson and Beth Israel Deaconess Medical center are now looking for 60,000 people to […]
A COVID-19 vaccine developed by Johnson & Johnson in partnership with Beth Israel Deaconess Medical Center has now entered its final stage of clinical trials, making it the fourth American […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/09/GBH.jpg400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2020-09-23 16:06:152020-09-24 16:07:18COVID-19 Vaccine Developed In Partnership With Beth Israel Reaches Final Stage Of Testing
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/09/BH.jpg378378Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2020-09-23 10:46:412020-09-24 10:47:34Johnson & Johnson begins large phase 3 study of COVID vaccine globally and in Boston
The company will become the first to test the simpler regimen of its candidate which is being developed by Janssen Pharmaceutical Companies, Dr. Dan Barouch, director of the Center for […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/05/nyt.png400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2020-09-23 08:49:282020-09-23 10:15:44Johnson & Johnson Begins Large Trial of Its One-Shot Vaccine
“The benefits of a single-shot vaccine are potentially profound in terms of mass immunization campaigns and global pandemic control,” Dr. Dan Barouch. Read Article
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/05/reuters.jpg363363Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2020-09-23 07:25:142020-09-23 10:15:13J&J kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/04/Boston-globe.jpg240240Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2020-09-23 06:45:312020-09-23 10:08:28Major study to start for COVID-19 vaccine developed by Johnson & Johnson, Beth Israel
Three other candidates have a head start, but J&J’s vaccine could be easier to administer and distribute if it is proved safe and effective. Read Article
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/07/WP.jpg400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2020-09-23 06:45:052020-09-23 10:20:03A single-shot coronavirus vaccine from Johnson & Johnson will be tested in 60,000 people
Beth Israel Deaconess Medical Center, a Harvard Medical School teaching hospital, Dan H. Barouch is heading a COVID-19 vaccine effort in a partnership with pharmaceutical company Johnson & Johnson. Read […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/09/CrimsonSeal-large-color_400x400.jpg400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2020-09-14 13:28:032020-09-14 13:28:03As Fall Arrives and Pressures Mount, Harvard Medical Researchers Press Forward on Two COVID Vaccine Trials
Another COVID-19 vaccine developed in Massachusetts entering Phase 3 trial
/in NewsAfter months of laboratory work and successful testing in rhesus macaque monkeys, researchers at Johnson & Johnson and Beth Israel Deaconess Medical center are now looking for 60,000 people to […]
COVID-19 Vaccine Developed In Partnership With Beth Israel Reaches Final Stage Of Testing
/in NewsA COVID-19 vaccine developed by Johnson & Johnson in partnership with Beth Israel Deaconess Medical Center has now entered its final stage of clinical trials, making it the fourth American […]
Johnson & Johnson’s Coronavirus Vaccine Enters Phase 3 Trial With Beth Israel
/in NewsJohnson & Johnson begins large phase 3 study of COVID vaccine globally and in Boston
/in NewsRead Article
Johnson & Johnson’s COVID-19 candidate enters third trial phase
/in NewsThe company will become the first to test the simpler regimen of its candidate which is being developed by Janssen Pharmaceutical Companies, Dr. Dan Barouch, director of the Center for […]
Johnson & Johnson Begins Large Trial of Its One-Shot Vaccine
/in NewsUnlike some of its competitors, Johnson & Johnson’s vaccine does not need to be frozen and may require just one shot instead of two. Read Article
J&J kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers
/in News“The benefits of a single-shot vaccine are potentially profound in terms of mass immunization campaigns and global pandemic control,” Dr. Dan Barouch. Read Article
Major study to start for COVID-19 vaccine developed by Johnson & Johnson, Beth Israel
/in NewsUp to 60,000 volunteers, including some in Boston, will take part in the trial following encouraging data from more limited testing. Read Article
A single-shot coronavirus vaccine from Johnson & Johnson will be tested in 60,000 people
/in NewsThree other candidates have a head start, but J&J’s vaccine could be easier to administer and distribute if it is proved safe and effective. Read Article
As Fall Arrives and Pressures Mount, Harvard Medical Researchers Press Forward on Two COVID Vaccine Trials
/in NewsBeth Israel Deaconess Medical Center, a Harvard Medical School teaching hospital, Dan H. Barouch is heading a COVID-19 vaccine effort in a partnership with pharmaceutical company Johnson & Johnson. Read […]